| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.157 | 3.013 | 1.654 | 0 | 0 | 27.777 | 23.713 |
| Total Income - EUR | - | - | - | 5.157 | 3.013 | 2.272 | 0 | 0 | 27.777 | 23.713 |
| Total Expenses - EUR | - | - | - | 1.080 | 2.759 | 2.027 | 6 | 0 | 20.040 | 17.446 |
| Gross Profit/Loss - EUR | - | - | - | 4.077 | 254 | 245 | -6 | 0 | 7.737 | 6.267 |
| Net Profit/Loss - EUR | - | - | - | 4.026 | 213 | 227 | -6 | 0 | 6.524 | 6.059 |
| Employees | - | - | - | 1 | 1 | 1 | 0 | 0 | 2 | 2 |
Check the financial reports for the company - Copiramidaco S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 134 | 59 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 4.618 | 4.144 | 4.514 | 4.248 | 205 | 8.051 | 11.368 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 5.581 | 10.381 |
| Cash | - | - | - | 4.618 | 4.144 | 4.514 | 4.248 | 205 | 2.470 | 987 |
| Shareholders Funds | - | - | - | 4.069 | 4.203 | 4.351 | 4.248 | 205 | 6.729 | 8.003 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 684 | 0 | 164 | 0 | 0 | 1.323 | 3.365 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Copiramidaco S.r.l.